|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Change in fair value of derivative warrant liabilities | |||||
| Income from cash held in the Trust Account | |||||
| Gain on forfeiture of deferred underwriting fee payable | |||||
| Benefit from credit loss | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses | |||||
| Prepaid expenses and due from related party | |||||
| Due from AERKOMM | |||||
| Accounts receivable | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Cash withdrawn from Trust Account in connection with Redemptions | |||||
| Cash deposited in the Trust Account | |||||
| Net cash provided by investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from Extension Promissory Note | |||||
| Proceeds from convertible promissory note - related party | |||||
| Repayment of promissory note - related party | |||||
| Redemption of ordinary shares | |||||
| Net cash used in financing activities | |||||
| Net change in cash | |||||
| Cash - beginning of the year | |||||
| Cash - end of the year | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Deferred underwriting fee reduction | |||||
| Remeasurement of Class A ordinary shares to redemption amount | |||||
| Conversion of Class B shares to Class A | |||||
Loading...